Products
Latest News
FAQ
Pharmaceutical Companies
Pharma Details
Gelesis, Inc.
🇺🇸
United States
Country
🇺🇸
United States
Ownership
Subsidiary
Established
2006-02-01
Employees
101
Market Cap
-
Website
http://www.gelesis.com
Clinical Trials
Related News
Study of Gelesis100 on Body Weight in Overweight and Obese Subjects With and Without Type 2 Diabetes
Not Applicable
Completed
Conditions
Overweight
Obesity
Interventions
Device: Gelesis100
Device: placebo
Subscribe
First Posted Date
2014-12-04
Last Posted Date
2022-08-30
Lead Sponsor
Gelesis, Inc.
Target Recruit Count
436
Registration Number
NCT02307279
Locations
🇪🇸
Investigative Site, Pamplona, Spain
Subscribe
Prev
1
2
Next
© Copyright 2025. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy